Live
- NASA Tracks Five Giant Asteroids on Close Approach to Earth Today
- Pushpa 2 Hits ₹1000 Crore in 6 Days: How It Compares to Other Top Indian Films
- Vivo X200 and X200 Pro Launched in India: Price, Specifications, and Features
- Nitin Gadkari Admits Feeling Embarrassed at Global Summits Over Rising Road Accidents in India
- Comprehensive Review on Indiramma Housing Survey and Welfare Initiatives Conducted via Video Conference
- Jogulamba Temple Records Rs 1.06 Crore Hundi Revenue in 150 Days
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
Common prostate cancer treatment linked with dementia
Men who undergo a testosterone-lowering therapy for the treatment of prostate cancer may be at an increased risk of dementia, a study showed Previous studies have shown men who undergo androgen deprivation therapy (ADT) may be at an increased risk of dementia, including Alzheimer\'s disease, compared to men who were not treated with the therapy.
Men who undergo a testosterone-lowering therapy for the treatment of prostate cancer may be at an increased risk of dementia, a study showed Previous studies have shown men who undergo androgen deprivation therapy (ADT) may be at an increased risk of dementia, including Alzheimer's disease, compared to men who were not treated with the therapy.
"Androgens play a key role in neuron maintenance and growth, so the longer you undergo this therapy to decrease androgens, the more it may impact the brain's normal functions," said lead author Kevin Nead, University of Pennsylvania. "This analysis tells us that the composite message of existing studies is that androgen deprivation therapy is associated with dementia," Nead added, in the paper published in the journal Prostate Cancer and Prostatic Diseases.
For the study, the team compiled data from four different global databases looking at studies on ADT patients and dementia and Alzheimer's. An analysis of more than 50,000 patients worldwide showed a consistent statistical link between men who underwent ADT for prostate cancer and men who developed dementia. "There's enough evidence of these links that patients should know about them when considering their options," Nead added.
